Received Jul 30, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | AMVB064A | IM / LA |
received the liquid conjugate component only; received the liquid conjugate component only; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a 16-year-old female patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVB064A, expiry date 31-DEC-2025) for prophylaxis. On 08-JUL-2025, the patient received Menveo (intramuscular, left deltoid). On 08-JUL-2025, an unknown time after receiving Menveo, the patient experienced inappropriate preparation of medication (Verbatim: received the liquid conjugate component only) and inappropriate dose of vaccine administered (Verbatim: received the liquid conjugate component only). On 08-JUL-2025, the outcome of the inappropriate preparation of medication was not applicable. The outcome of the inappropriate dose of vaccine administered was not applicable. Additional Information: GSK Receipt Date: 17-JUL-2025 The reporter was a nurse who called to report that a female patient had received only the liquid conjugate component of Menveo in her left deltoid on 8-JUL-2025, which led to Inappropriate preparation of medication and Inappropriate dose of vaccine administered. All the information that was provided about this adverse event was reported.; Sender's Comments: US-GSK-US2025091770:same reporter, Different patient, 1 of 3 report US-GSK-US2025091796:same reporter, Different patient, 3 of 3 report